# TransDigm Group INC: financial statements, quarterly

TDG · NYSE · CIK 1260221 · [Industrials](/sectors/industrials.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/tdg.md) · [Financials](/companies/tdg/financials.md) · [Filings](/companies/tdg/filings.md) · [Insiders](/companies/tdg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tdg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,852 d](/filings/0001260221-24-000083.md) | [1,789](/filings/0001260221-25-000014.md) | [1,919](/filings/0001260221-25-000026.md) | [2,046](/filings/0001260221-25-000051.md) | [2,186 d](/filings/0001260221-24-000083.md) | [2,006](/filings/0001260221-26-000017.md) | [2,150](/filings/0001260221-26-000040.md) | [2,237](/filings/0001260221-26-000053.md) | [2,437 d](/filings/0001260221-25-000081.md) | [2,285](/filings/0001260221-26-000017.md) | [2,544](/filings/0001260221-26-000040.md) | [2,741](/filings/0001260221-26-000053.md) |
| Cost of revenue | $m | [760 d](/filings/0001260221-25-000081.md) | [747](/filings/0001260221-25-000014.md) | [767](/filings/0001260221-25-000026.md) | [826](/filings/0001260221-25-000051.md) | [927 d](/filings/0001260221-25-000081.md) | [771](/filings/0001260221-26-000017.md) | [876](/filings/0001260221-26-000040.md) | [905](/filings/0001260221-26-000053.md) | [967 d](/filings/0001260221-25-000081.md) | [933](/filings/0001260221-26-000017.md) | [1,033](/filings/0001260221-26-000040.md) | [1,113](/filings/0001260221-26-000053.md) |
| Gross profit | $m | [1,092 d](/filings/0001260221-25-000081.md) | [1,042](/filings/0001260221-25-000014.md) | [1,152](/filings/0001260221-25-000026.md) | [1,220](/filings/0001260221-25-000051.md) | [1,259 d](/filings/0001260221-25-000081.md) | [1,235](/filings/0001260221-26-000017.md) | [1,274](/filings/0001260221-26-000040.md) | [1,332](/filings/0001260221-26-000053.md) | [1,470 d](/filings/0001260221-25-000081.md) | [1,352](/filings/0001260221-26-000017.md) | [1,511](/filings/0001260221-26-000040.md) | [1,628](/filings/0001260221-26-000053.md) |
| Selling, general and administrative | $m | [202 d](/filings/0001260221-25-000081.md) | [220](/filings/0001260221-25-000014.md) | [248](/filings/0001260221-25-000026.md) | [248](/filings/0001260221-25-000051.md) | [265 d](/filings/0001260221-25-000081.md) | [211](/filings/0001260221-26-000017.md) | [236](/filings/0001260221-26-000040.md) | [242](/filings/0001260221-26-000053.md) | [256 d](/filings/0001260221-25-000081.md) | [254](/filings/0001260221-26-000017.md) | [273](/filings/0001260221-26-000040.md) | [332](/filings/0001260221-26-000053.md) |
| Operating income | $m | [856 d](/filings/0001260221-25-000081.md) | [787](/filings/0001260221-25-000014.md) | [867](/filings/0001260221-25-000026.md) | [934](/filings/0001260221-25-000051.md) | [943 d](/filings/0001260221-25-000081.md) | [974](/filings/0001260221-26-000017.md) | [991](/filings/0001260221-26-000040.md) | [1,039](/filings/0001260221-26-000053.md) | [1,161 d](/filings/0001260221-25-000081.md) | [1,042](/filings/0001260221-26-000017.md) | [1,178](/filings/0001260221-26-000040.md) | [1,227](/filings/0001260221-26-000053.md) |
| Interest expense | $m | not reported | [300](/filings/0001260221-25-000014.md) | [326](/filings/0001260221-25-000026.md) | [316](/filings/0001260221-25-000051.md) | not reported | [378](/filings/0001260221-26-000017.md) | [378](/filings/0001260221-26-000040.md) | [397](/filings/0001260221-26-000053.md) | not reported | [475](/filings/0001260221-26-000017.md) | [484](/filings/0001260221-26-000040.md) | [514](/filings/0001260221-26-000053.md) |
| Income tax | $m | [136 d](/filings/0001260221-25-000081.md) | [106](/filings/0001260221-25-000014.md) | [115](/filings/0001260221-25-000026.md) | [141](/filings/0001260221-25-000051.md) | [138 d](/filings/0001260221-25-000081.md) | [126](/filings/0001260221-26-000017.md) | [143](/filings/0001260221-26-000040.md) | [142](/filings/0001260221-26-000053.md) | [144 d](/filings/0001260221-25-000081.md) | [127](/filings/0001260221-26-000017.md) | [164](/filings/0001260221-26-000040.md) | [173](/filings/0001260221-26-000053.md) |
| Net income | $m | [415 d](/filings/0001260221-25-000081.md) | [382](/filings/0001260221-25-000051.md) | [403](/filings/0001260221-25-000051.md) | [461](/filings/0001260221-25-000051.md) | [468 d](/filings/0001260221-25-000081.md) | [493](/filings/0001260221-26-000053.md) | [479](/filings/0001260221-26-000053.md) | [492](/filings/0001260221-26-000053.md) | [610 d](/filings/0001260221-25-000081.md) | [445](/filings/0001260221-26-000053.md) | [535](/filings/0001260221-26-000053.md) | [539](/filings/0001260221-26-000053.md) |
| Diluted EPS | $ per share | not reported | [4.87](/filings/0001260221-25-000014.md) | [6.97](/filings/0001260221-25-000026.md) | [7.96](/filings/0001260221-25-000051.md) | not reported | [7.62](/filings/0001260221-26-000017.md) | [8.24](/filings/0001260221-26-000040.md) | [8.47](/filings/0001260221-26-000053.md) | not reported | [6.62](/filings/0001260221-26-000017.md) | [9.20](/filings/0001260221-26-000040.md) | [9.39](/filings/0001260221-26-000053.md) |
| Basic EPS | $ per share | not reported | [4.87](/filings/0001260221-25-000014.md) | [6.97](/filings/0001260221-25-000026.md) | [7.96](/filings/0001260221-25-000051.md) | not reported | [7.62](/filings/0001260221-26-000017.md) | [8.24](/filings/0001260221-26-000040.md) | [8.47](/filings/0001260221-26-000053.md) | not reported | [6.62](/filings/0001260221-26-000017.md) | [9.20](/filings/0001260221-26-000040.md) | [9.39](/filings/0001260221-26-000053.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [3.5](/filings/0001260221-24-000083.md) | not reported | [4.3](/filings/0001260221-24-000046.md) | [3.4](/filings/0001260221-24-000069.md) | [6.3](/filings/0001260221-25-000081.md) | [2.5](/filings/0001260221-25-000014.md) | [2.4](/filings/0001260221-25-000026.md) | [2.8](/filings/0001260221-25-000051.md) | [2.8](/filings/0001260221-26-000053.md) | [2.5](/filings/0001260221-26-000017.md) | [3.9](/filings/0001260221-26-000040.md) | [2.8](/filings/0001260221-26-000053.md) |
| Current assets | $bn | [6.7](/filings/0001260221-24-000083.md) | [7.4](/filings/0001260221-24-000021.md) | [8.3](/filings/0001260221-24-000046.md) | [7.1](/filings/0001260221-24-000069.md) | [10.0](/filings/0001260221-25-000081.md) | [6.2](/filings/0001260221-25-000014.md) | [6.4](/filings/0001260221-25-000026.md) | [6.9](/filings/0001260221-25-000051.md) | [7.0](/filings/0001260221-26-000053.md) | [7.0](/filings/0001260221-26-000017.md) | [8.6](/filings/0001260221-26-000040.md) | [7.8](/filings/0001260221-26-000053.md) |
| Total assets | $bn | [20.0](/filings/0001260221-25-000081.md) | [20.7](/filings/0001260221-24-000021.md) | [21.6](/filings/0001260221-24-000046.md) | [21.8](/filings/0001260221-24-000069.md) | [25.6](/filings/0001260221-25-000081.md) | [21.5](/filings/0001260221-25-000014.md) | [21.9](/filings/0001260221-25-000026.md) | [22.7](/filings/0001260221-25-000051.md) | [22.9](/filings/0001260221-26-000053.md) | [23.8](/filings/0001260221-26-000017.md) | [25.4](/filings/0001260221-26-000040.md) | [26.8](/filings/0001260221-26-000053.md) |
| Current liabilities | $bn | [1.6](/filings/0001260221-24-000083.md) | [1.8](/filings/0001260221-24-000021.md) | [2.2](/filings/0001260221-24-000046.md) | [1.9](/filings/0001260221-24-000069.md) | [6.3](/filings/0001260221-25-000081.md) | [2.3](/filings/0001260221-25-000014.md) | [2.1](/filings/0001260221-25-000026.md) | [2.2](/filings/0001260221-25-000051.md) | [2.2](/filings/0001260221-26-000053.md) | [2.5](/filings/0001260221-26-000017.md) | [2.4](/filings/0001260221-26-000040.md) | [2.6](/filings/0001260221-26-000053.md) |
| Total liabilities | $bn | [21.9](/filings/0001260221-24-000083.md) | [24.2](/filings/0001260221-24-000021.md) | [24.6](/filings/0001260221-24-000046.md) | [24.3](/filings/0001260221-24-000069.md) | [31.9](/filings/0001260221-25-000081.md) | [27.8](/filings/0001260221-25-000014.md) | [27.6](/filings/0001260221-25-000026.md) | [27.7](/filings/0001260221-25-000051.md) | [32.6](/filings/0001260221-26-000053.md) | [33.0](/filings/0001260221-26-000017.md) | [34.8](/filings/0001260221-26-000040.md) | [36.5](/filings/0001260221-26-000053.md) |
| Long-term debt | $bn | [19.4](/filings/0001260221-24-000083.md) | [21.4](/filings/0001260221-24-000021.md) | [22.0](/filings/0001260221-24-000046.md) | [21.4](/filings/0001260221-24-000069.md) | [24.4](/filings/0001260221-25-000081.md) | [24.4](/filings/0001260221-25-000014.md) | [24.4](/filings/0001260221-25-000026.md) | [24.4](/filings/0001260221-25-000051.md) | [29.3](/filings/0001260221-25-000081.md) | [29.3](/filings/0001260221-26-000017.md) | [31.3](/filings/0001260221-26-000040.md) | [32.8](/filings/0001260221-26-000053.md) |
| Current portion of debt | $bn | [0.1](/filings/0001260221-24-000083.md) | [0.1](/filings/0001260221-24-000021.md) | [0.6](/filings/0001260221-24-000046.md) | [0.1](/filings/0001260221-24-000069.md) | [0.1](/filings/0001260221-25-000081.md) | [0.1](/filings/0001260221-25-000014.md) | [0.1](/filings/0001260221-25-000026.md) | [0.1](/filings/0001260221-25-000051.md) | [0.1](/filings/0001260221-26-000053.md) | [0.1](/filings/0001260221-26-000017.md) | [0.1](/filings/0001260221-26-000040.md) | [0.1](/filings/0001260221-26-000053.md) |
| Shareholders' equity | $bn | [(2.0)](/filings/0001260221-24-000083.md) | [(3.5)](/filings/0001260221-24-000021.md) | [(3.0)](/filings/0001260221-24-000046.md) | [(2.5)](/filings/0001260221-24-000069.md) | [(6.3)](/filings/0001260221-25-000081.md) | [(6.3)](/filings/0001260221-25-000014.md) | [(5.7)](/filings/0001260221-25-000026.md) | [(5.0)](/filings/0001260221-25-000051.md) | [(9.7)](/filings/0001260221-26-000053.md) | [(9.3)](/filings/0001260221-26-000017.md) | [(9.4)](/filings/0001260221-26-000040.md) | [(9.8)](/filings/0001260221-26-000053.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [462 d](/filings/0001260221-25-000081.md) | [636](/filings/0001260221-25-000014.md) | [229 d](/filings/0001260221-25-000026.md) | [608 d](/filings/0001260221-25-000051.md) | [572 d](/filings/0001260221-25-000081.md) | [752](/filings/0001260221-26-000017.md) | [148 d](/filings/0001260221-26-000040.md) | [631 d](/filings/0001260221-26-000053.md) | [507 d](/filings/0001260221-25-000081.md) | [832](/filings/0001260221-26-000017.md) | [135 d](/filings/0001260221-26-000040.md) | [724 d](/filings/0001260221-26-000053.md) |
| Capital expenditure | $m | [37.0 d](/filings/0001260221-25-000081.md) | [36.0](/filings/0001260221-25-000014.md) | [48.0 d](/filings/0001260221-25-000026.md) | [40.0 d](/filings/0001260221-25-000051.md) | [41.0 d](/filings/0001260221-25-000081.md) | [42.0](/filings/0001260221-26-000017.md) | [56.0 d](/filings/0001260221-26-000040.md) | [58.0 d](/filings/0001260221-26-000053.md) | [66.0 d](/filings/0001260221-25-000081.md) | [60.0](/filings/0001260221-26-000017.md) | [71.0 d](/filings/0001260221-26-000040.md) | [74.0 d](/filings/0001260221-26-000053.md) |
| Dividends paid | $m | [0.0 d](/filings/0001260221-25-000081.md) | [2,038](/filings/0001260221-25-000014.md) | [0.0 d](/filings/0001260221-25-000026.md) | [0.0 d](/filings/0001260221-25-000051.md) | [0.0 d](/filings/0001260221-25-000081.md) | [4,396](/filings/0001260221-26-000017.md) | [0.0 d](/filings/0001260221-26-000040.md) | [0.0 d](/filings/0001260221-26-000053.md) | [(4,237) d](/filings/0001260221-25-000081.md) | [59.0](/filings/0001260221-26-000017.md) | [0.0 d](/filings/0001260221-26-000040.md) | [0.0 d](/filings/0001260221-26-000053.md) |
| Share repurchases | $m | [0.0 d](/filings/0001260221-25-000081.md) | [0.0](/filings/0001260221-25-000014.md) | [0.0 d](/filings/0001260221-25-000026.md) | [0.0 d](/filings/0001260221-25-000051.md) | [0.0 d](/filings/0001260221-25-000081.md) | [316](/filings/0001260221-26-000017.md) | [53.0 d](/filings/0001260221-26-000040.md) | [131 d](/filings/0001260221-26-000053.md) | [0.0 d](/filings/0001260221-25-000081.md) | [106](/filings/0001260221-26-000017.md) | [615 d](/filings/0001260221-26-000040.md) | [1,086 d](/filings/0001260221-26-000053.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends, us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-04-01) | Q3 FY2023 (2023-07-01) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [57.1](/filings/0001260221-24-000021.md) | [57.1](/filings/0001260221-24-000046.md) | [57.2](/filings/0001260221-24-000069.md) | [57.7](/filings/0001260221-25-000014.md) | [57.8](/filings/0001260221-25-000026.md) | [57.9](/filings/0001260221-25-000051.md) | [58.3](/filings/0001260221-26-000017.md) | [58.1](/filings/0001260221-26-000040.md) | [58.1](/filings/0001260221-26-000053.md) | [58.2](/filings/0001260221-26-000017.md) | [58.2](/filings/0001260221-26-000040.md) | [57.4](/filings/0001260221-26-000053.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 55,276,525 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001260221-26-000053.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.